Home › Upcoming votes › Oaktree Acquisition Corp. III Life Sciences
This meeting took place on October 16, 2026. Official results not yet filed. Companies report them on Form 8-K, usually within four business days of the meeting; they will appear here once they have been read.
The deadline as the proxy statement states it: “Votes submitted by mail must be received by 5:00 p.m., Eastern Time, on October 15, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
As listed in Oaktree Acquisition Corp. III Life Sciences’s proxy statement, with the board’s recommendation on each item. The company has filed 2 sets of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends |
|---|---|---|---|
| 1 | THE EXTENSION AMENDMENT PROPOSAL | Board | For |
| 2 | THE ADJOURNMENT PROPOSAL Adjournment |
Board | For |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the filing automatically and checked against the proxy’s own item count and voting card; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.